HMOX1 and viral infectious disease: Previous studies have shown that the therapeutic efficacy of RosA treatment on various stimulus-mediated lung injuries was due to increased levels of HO-1 [46, 47], but it is unclear whether the upregulation of HO-1 by RosA is associated with its elevated effects on h-PGDS during virus infection.